Development of RNA Base Editing Technologies for Precision Medicines with Axiomer® and Trident® presented at TIDES USA 2022 by Gerard Platenburg - ProQR Therapeutics.
… to changing lives through the creation of transformative RNA therapies for genetic eye diseases, will webcast a … its clinical stage pipeline programs and the Axiomer ® RNAediting platform. ProQR leadership will highlight key …
… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer ™ RNAediting technology platform, today reported its financial …
… to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that … RNA therapies for genetic eye diseases and our proprietary RNA-editing platform technology.” “I first met Daniel more than a …
… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer ™ RNAediting technology platform, today reported its financial …
